These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 29749478)
1. Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells. Jeon JY; Lee JS; Park ER; Shen YN; Kim MY; Shin HJ; Joo HY; Cho EH; Moon SM; Shin US; Park SH; Han CJ; Choi DW; Gu MB; Kim SB; Lee KH Oncol Rep; 2018 Jul; 40(1):536-544. PubMed ID: 29749478 [TBL] [Abstract][Full Text] [Related]
2. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma. Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221 [TBL] [Abstract][Full Text] [Related]
3. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin. Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651 [TBL] [Abstract][Full Text] [Related]
4. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy. Shimizu D; Kanda M; Sugimoto H; Shibata M; Tanaka H; Takami H; Iwata N; Hayashi M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y Int J Oncol; 2017 Feb; 50(2):381-386. PubMed ID: 28101581 [TBL] [Abstract][Full Text] [Related]
5. PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma. Jiang H; Zhu Y; Zhou Z; Xu J; Jin S; Xu K; Zhang H; Sun Q; Wang J; Xu J Cancer Med; 2018 Mar; 7(3):869-882. PubMed ID: 29441724 [TBL] [Abstract][Full Text] [Related]
6. SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression. Zhou Z; Chen Z; Zhou Q; Meng S; Shi J; Mui S; Jiang H; Lin J; He G; Li W; Zhang J; Wang J; He C; Yan Y; Xiao Z Cancer Sci; 2024 May; 115(5):1587-1601. PubMed ID: 38438251 [TBL] [Abstract][Full Text] [Related]
7. Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α. Zheng BN; Ding CH; Chen SJ; Zhu K; Shao J; Feng J; Xu WP; Cai LY; Zhu CP; Duan W; Ding J; Zhang X; Luo C; Xie WF Theranostics; 2019; 9(9):2606-2617. PubMed ID: 31131056 [No Abstract] [Full Text] [Related]
8. Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma. Wang B; Fang J; Qu L; Cao Z; Zhou J; Deng B Tumour Biol; 2015 Sep; 36(9):6901-8. PubMed ID: 25851347 [TBL] [Abstract][Full Text] [Related]
9. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Li Z; Zhang J; Liu X; Li S; Wang Q; Di Chen ; Hu Z; Yu T; Ding J; Li J; Yao M; Fan J; Huang S; Gao Q; Zhao Y; He X Nat Commun; 2018 Apr; 9(1):1572. PubMed ID: 29679004 [TBL] [Abstract][Full Text] [Related]
10. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
11. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo. Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817 [TBL] [Abstract][Full Text] [Related]
12. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Zhang J; Zhang DL; Jiao XL; Dong Q Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232 [TBL] [Abstract][Full Text] [Related]
13. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma. Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016 [TBL] [Abstract][Full Text] [Related]
14. Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5. Tian Y; Yang W; Yang R; Zhang Q; Hao L; Bian E; Yang Y; Huang X; Wu Y; Zhang B Toxicol Appl Pharmacol; 2022 Jan; 435():115829. PubMed ID: 34919946 [TBL] [Abstract][Full Text] [Related]
15. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
16. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway. Zhu K; Peng Y; Hu J; Zhan H; Yang L; Gao Q; Jia H; Luo R; Dai Z; Tang Z; Fan J; Zhou J Carcinogenesis; 2020 Apr; 41(2):130-138. PubMed ID: 31498866 [TBL] [Abstract][Full Text] [Related]
17. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117 [TBL] [Abstract][Full Text] [Related]
18. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma. Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164 [TBL] [Abstract][Full Text] [Related]
19. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
20. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]